世界のメシル酸イマチニブ薬市場 2019年

【英語タイトル】Global Imatinib Mesylate Drugs Market Professional Survey Report 2019

QYResearchが出版した調査資料(QYR20FB02208)・商品コード:QYR20FB02208
・発行会社(調査会社):QYResearch
・発行日:2019年11月(※2024年版があります。お問い合わせください)
・ページ数:104
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後3営業日)
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,500 ⇒換算¥518,000見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,250 ⇒換算¥777,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,000 ⇒換算¥1,036,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートは、メシル酸イマチニブ薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、100mg、400mgに、用途別には、病院、薬局にセグメント区分し、メシル酸イマチニブ薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・メシル酸イマチニブ薬の世界市場概要
・メシル酸イマチニブ薬の製造コスト構成分析
・メシル酸イマチニブ薬の開発・製造工場分析
・主要メーカーの主な指標(生産能力、売上、価格分析)
・メシル酸イマチニブ薬の地域別分析(生産、売上、主要メーカー、輸出・輸入)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・メシル酸イマチニブ薬のセグメント分析(種類別)
(100mg、400mg)
・メシル酸イマチニブ薬のセグメント分析(用途別)
(病院、薬局)
・メシル酸イマチニブ薬の主要メーカー別分析(生産拠点、製品概要、生産・売上実績)
(Novartis)
・メシル酸イマチニブ薬の市場規模予測(2019年~2025年)
(北米、ヨーロッパ、中国、日本国内、東南アジア、インド)
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス(市場動向、機会、成長要因、課題、影響因子)
...
【レポートの概要】

Imatinib is a medication used to treat cancer.
The global Imatinib Mesylate Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Imatinib Mesylate Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Imatinib Mesylate Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Imatinib Mesylate Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Imatinib Mesylate Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novartis

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
100mg
400mg

Segment by Application
Hospital
Pharmacy

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Imatinib Mesylate Drugs
1.1 Definition of Imatinib Mesylate Drugs
1.2 Imatinib Mesylate Drugs Segment by Type
1.2.1 Global Imatinib Mesylate Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 100mg
1.2.3 400mg
1.3 Imatinib Mesylate Drugs Segment by Applications
1.3.1 Global Imatinib Mesylate Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Global Imatinib Mesylate Drugs Overall Market
1.4.1 Global Imatinib Mesylate Drugs Revenue (2014-2025)
1.4.2 Global Imatinib Mesylate Drugs Production (2014-2025)
1.4.3 North America Imatinib Mesylate Drugs Status and Prospect (2014-2025)
1.4.4 Europe Imatinib Mesylate Drugs Status and Prospect (2014-2025)
1.4.5 China Imatinib Mesylate Drugs Status and Prospect (2014-2025)
1.4.6 Japan Imatinib Mesylate Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Imatinib Mesylate Drugs Status and Prospect (2014-2025)
1.4.8 India Imatinib Mesylate Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Imatinib Mesylate Drugs
2.3 Manufacturing Process Analysis of Imatinib Mesylate Drugs
2.4 Industry Chain Structure of Imatinib Mesylate Drugs

3 Development and Manufacturing Plants Analysis of Imatinib Mesylate Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Imatinib Mesylate Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Imatinib Mesylate Drugs
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Imatinib Mesylate Drugs Production and Capacity Analysis
4.2 Imatinib Mesylate Drugs Revenue Analysis
4.3 Imatinib Mesylate Drugs Price Analysis
4.4 Market Concentration Degree

5 Imatinib Mesylate Drugs Regional Market Analysis
5.1 Imatinib Mesylate Drugs Production by Regions
5.1.1 Global Imatinib Mesylate Drugs Production by Regions
5.1.2 Global Imatinib Mesylate Drugs Revenue by Regions
5.2 Imatinib Mesylate Drugs Consumption by Regions
5.3 North America Imatinib Mesylate Drugs Market Analysis
5.3.1 North America Imatinib Mesylate Drugs Production
5.3.2 North America Imatinib Mesylate Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Imatinib Mesylate Drugs Import and Export
5.4 Europe Imatinib Mesylate Drugs Market Analysis
5.4.1 Europe Imatinib Mesylate Drugs Production
5.4.2 Europe Imatinib Mesylate Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Imatinib Mesylate Drugs Import and Export
5.5 China Imatinib Mesylate Drugs Market Analysis
5.5.1 China Imatinib Mesylate Drugs Production
5.5.2 China Imatinib Mesylate Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Imatinib Mesylate Drugs Import and Export
5.6 Japan Imatinib Mesylate Drugs Market Analysis
5.6.1 Japan Imatinib Mesylate Drugs Production
5.6.2 Japan Imatinib Mesylate Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Imatinib Mesylate Drugs Import and Export
5.7 Southeast Asia Imatinib Mesylate Drugs Market Analysis
5.7.1 Southeast Asia Imatinib Mesylate Drugs Production
5.7.2 Southeast Asia Imatinib Mesylate Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Imatinib Mesylate Drugs Import and Export
5.8 India Imatinib Mesylate Drugs Market Analysis
5.8.1 India Imatinib Mesylate Drugs Production
5.8.2 India Imatinib Mesylate Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Imatinib Mesylate Drugs Import and Export

6 Imatinib Mesylate Drugs Segment Market Analysis (by Type)
6.1 Global Imatinib Mesylate Drugs Production by Type
6.2 Global Imatinib Mesylate Drugs Revenue by Type
6.3 Imatinib Mesylate Drugs Price by Type

7 Imatinib Mesylate Drugs Segment Market Analysis (by Application)
7.1 Global Imatinib Mesylate Drugs Consumption by Application
7.2 Global Imatinib Mesylate Drugs Consumption Market Share by Application (2014-2019)

8 Imatinib Mesylate Drugs Major Manufacturers Analysis
8.1 Novartis
8.1.1 Novartis Imatinib Mesylate Drugs Production Sites and Area Served
8.1.2 Novartis Product Introduction, Application and Specification
8.1.3 Novartis Imatinib Mesylate Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served

9 Development Trend of Analysis of Imatinib Mesylate Drugs Market
9.1 Global Imatinib Mesylate Drugs Market Trend Analysis
9.1.1 Global Imatinib Mesylate Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Imatinib Mesylate Drugs Regional Market Trend
9.2.1 North America Imatinib Mesylate Drugs Forecast 2019-2025
9.2.2 Europe Imatinib Mesylate Drugs Forecast 2019-2025
9.2.3 China Imatinib Mesylate Drugs Forecast 2019-2025
9.2.4 Japan Imatinib Mesylate Drugs Forecast 2019-2025
9.2.5 Southeast Asia Imatinib Mesylate Drugs Forecast 2019-2025
9.2.6 India Imatinib Mesylate Drugs Forecast 2019-2025
9.3 Imatinib Mesylate Drugs Market Trend (Product Type)
9.4 Imatinib Mesylate Drugs Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Imatinib Mesylate Drugs Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer



【掲載企業】

Novartis

★調査レポート[世界のメシル酸イマチニブ薬市場 2019年] (コード:QYR20FB02208)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のメシル酸イマチニブ薬市場 2019年]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆